Related Experiment Video
Updated: Nov 22, 2025
10:14
Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets
Published on: February 16, 2020
6.7K
Clinical islet transplantation: Current progress and new frontiers
Braulio A Marfil-Garza1, Andrew Mark James Shapiro1,2, Tatsuya Kin2
1Department of Surgery, University of Alberta, Edmonton, AB, Canada.
Journal of Hepato-Biliary-Pancreatic Sciences
|January 8, 2021
Summary
Islet transplantation (IT) offers a robust treatment for type 1 diabetes patients with hypoglycemia. Continued research aims to overcome challenges and advance IT as a potential cure.
Area of Science:
- Endocrinology
- Immunology
- Regenerative Medicine
Background:
- Type 1 diabetes (T1D) management remains challenging, particularly for patients with severe hypoglycemia.
- Islet transplantation (IT) has emerged as a viable treatment option for select T1D patients.
- Despite progress, widespread application of IT faces significant hurdles.
Purpose of the Study:
- To review the historical milestones and clinical success of islet transplantation.
- To discuss current challenges impeding broader IT accessibility.
- To propose potential solutions and explore future directions in clinical IT.
Main Methods:
- Literature review of historical data and current research on islet transplantation.
- Analysis of challenges in IT efficacy, accessibility, and long-term outcomes.
- Exploration of emerging strategies and future research frontiers.
Main Results:
- IT has evolved into a successful therapy for specific T1D patient groups.
- Significant challenges persist, including graft survival, immune rejection, and scalability.
- Promising solutions and future research avenues are being explored.
Conclusions:
- Islet transplantation is a proven therapy for select type 1 diabetes patients.
- Addressing current challenges is crucial for expanding IT's clinical impact.
- Future research holds potential for optimizing IT and moving towards a cure.
